title: Does the sequence of taxane administration affect the outcome of patients with breast cancer in the adjuvant and neoadjuvant settings?
authors.forename: Ali
authors.initials: A
authors.lastname: Alkan
authors.forename: Ugur
authors.initials: U
authors.lastname: Sahin
authors.forename: Kadri
authors.initials: K
authors.lastname: Altundag
mesh_terms: D018943:Anthracyclines / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000188:drug therapy*; D001952:Bridged-Ring Compounds / Q000008:administration & dosage*; D017024:Chemotherapy, Adjuvant; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D020360:Neoadjuvant Therapy; D043823:Taxoids / Q000008:administration & dosage*
chemical_list: D018943:Anthracyclines; D001952:Bridged-Ring Compounds; D043823:Taxoids; C080625:taxane